Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,485.49
(
-0.25%
)
News Focus
News Focus

Replies to post #257655 on Anavex Life Sciences Corp (AVXL)

Replies to #257655 on Anavex Life Sciences Corp (AVXL)
icon url

Investor2014

07/05/20 11:30 AM

#257668 RE: XenaLives #257655

I agree TGA could issue PA based on the PDD P2 trial subgroup analysis, but imo that is less likely than a P3 PM trial.